TAM
PCRX icon

THB Asset Management’s Pacira BioSciences PCRX Stock Holding History

THB Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$875K Sell
14,627
-1,815
-11% -$106K 0.2% 121
2020
Q3 		$988K Sell
16,442
-18,469
-53% -$1.07M 0.27% 103
2020
Q2 		$1.83M Buy
+34,911
New +$1.46M 0.53% 73

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

THB Asset Management's PCRX Position: Q4 2020 in Review

THB Asset Management reduced its Pacira BioSciences (PCRX) stake by 11% in Q4 2020, selling an estimated $106K and leaving 14,627 shares worth $875K. The position accounts for 0.2% of the portfolio, ranked #121.

THB Asset Management first reported a position in PCRX in Q2 2020 and has held it in 3 quarters since. The position peaked at $1.83M in Q2 2020. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2020.

  • THB Asset Management held 14,627 shares of Pacira BioSciences worth $875K as of Q4 2020.
  • THB Asset Management sold 1,815 Pacira BioSciences shares in Q4 2020, an estimated $106K.
  • Pacira BioSciences made up 0.2% of THB Asset Management's portfolio in Q4 2020, its #121 holding.
  • THB Asset Management first reported a position in Pacira BioSciences in Q2 2020 and has held it in 3 quarters since.
  • THB Asset Management's Pacira BioSciences position peaked at $1.83M in Q2 2020.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.